ePrivacy and GPDR Cookie Consent by Cookie Consent

Frequently asked questions

All you need to know about OncoDNA biomarker tests

Scroll down to discover


A scientific paper showed that OncoDNA provided information on available treatments in 92% of patients with advanced solid cancer. However, each cancer is different and it may also be that no alternative is found. The effectiveness of the biomarker test will depend on your type of cancer, its severity, the treatments you have already received, and many other factors. Feel free to ask your oncologist to contact us to assess together the potential clinical benefits in your particular case.

Your oncologist can order the biomarker tests that best fit your clinical situation via OncoSHARE. OncoSHARE is a web platform on which it takes just a few minutes to create a secure account and place orders. Your oncologist will receive the invoice and the kit to be used in order to send us your sample (tumour tissue specimen or/and blood sample). Once we receive your payment and sample(s), we will perform the analysis in our certified laboratory. Your oncologist will be notified as soon as the report with all test results and our therapeutic recommendations is available on OncoSHARE.

After ordering the test that you need via the OncoSHARE web platform, your oncologist will receive a kit that he/she will use to send us your tumour tissue or/and blood sample. You will also be asked to settle your invoice. Once we receive your payment and sample(s), we will perform the analysis in our certified laboratory. Your oncologist will be notified as soon as the results are available (7 to 10 working days), so that he/she can check the report with our therapeutic recommendations.

We do not advise to use our tests for early-stage cancers (stage 1 or 2), as well as for liquid tumors (i.e. leukemia, myeloma). We also do not analyse paediatric tumours (patients aged ≤ 18 years), except for glioblastoma cases. In summary, we recommend using our biomarker tests for stage 3 or 4 solid cancers in adults (except for glioblastoma patients).

We cannot guarantee that all suggested treatments will be available and/or reimbursed in your country. In some cases, if a treatment is not officially available or reimbursed, you could enroll in a clinical trial. Do not hesitate to ask your oncologist about the best options.

Our biomarker tests are designed to provide your oncologist with the most comprehensive information to make the best choice of treatment. However, cancer is a complex disease that evolves over time, and therefore it is very tricky to predict the efficiency of a treatment. What we do is to provide you with the best treatment options based on scientific knowledge.

Yes, our biomarker tests may provide your oncologist with insights on your response to immunotherapy. We test a wide range of markers of sensitivity to immunotherapy and provide an immunogram to better visualise the results. However, we may also recommend other treatment options such as hormonal therapy, chemotherapy and targeted therapy.

Cannot find what you are looking for? Contact us! Our Patient Support Teams are available to answer all your questions from Monday to Friday.